DrAIStudio

Frontiers in Oncology call for papers

Current call-for-papers opportunities for Frontiers in Oncology. Ranking signals: Indexed (Active), JIF 3.3. Use the official publisher page to verify scope and submission rules.

Accepting CFPs for Frontiers in Oncology

AI-Driven Prognostic Models in Melanoma

Deadline 2027-03-05FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Melanoma care has progressed substantially with improved staging frameworks and the adoption of targeted therapies and immune checkpoint inhibitors, yet outc...

AI-Driven Prognostic Models in Melanoma

Deadline 2027-03-05FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Melanoma care has progressed substantially with improved staging frameworks and the adoption of targeted therapies and immune checkpoint inhibitors, yet outc...

Immunotherapy for Rare and Hard-to-Treat Skin Cancers: Molecular Mechanisms, Clinical Strategies, and Toxicity Management

Deadline 2027-03-05FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Rare and hard-to-treat skin cancers, such as Merkel cell carcinoma, advanced cutaneous squamous cell carcinoma, refractory basal cell carcinoma, atypical fib...

Immunotherapy for Rare and Hard-to-Treat Skin Cancers: Molecular Mechanisms, Clinical Strategies, and Toxicity Management

Deadline 2027-03-05FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Rare and hard-to-treat skin cancers, such as Merkel cell carcinoma, advanced cutaneous squamous cell carcinoma, refractory basal cell carcinoma, atypical fib...

Stromal and Metabolic Drivers of the Tumor Microenvironment in Colorectal Cancer

Deadline 2027-03-05FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Colorectal cancer (CRC) ranks among the most prevalent and lethal malignancies worldwide, with disease progression shaped not only by tumor cell-intrinsic ge...

Stromal and Metabolic Drivers of the Tumor Microenvironment in Colorectal Cancer

Deadline 2027-03-05FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Colorectal cancer (CRC) ranks among the most prevalent and lethal malignancies worldwide, with disease progression shaped not only by tumor cell-intrinsic ge...

Neuro-Immune-Tumor Network: Multidimensional Regulatory Mechanisms in the Tumor Microenvironment

Deadline 2027-03-06FrontiersIndexed (Active)

Journal: Frontiers in Oncology

The tumor microenvironment (TME) is a complex ecosystem consisting of tumor cells, immune cells, nerve fibers, and the extracellular matrix, whose dynamic in...

Neuro-Immune-Tumor Network: Multidimensional Regulatory Mechanisms in the Tumor Microenvironment

Deadline 2027-03-06FrontiersIndexed (Active)

Journal: Frontiers in Oncology

The tumor microenvironment (TME) is a complex ecosystem consisting of tumor cells, immune cells, nerve fibers, and the extracellular matrix, whose dynamic in...

Future Directions in Genitourinary Oncology

Deadline 2027-03-07FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Genitourinary oncology is being reshaped by advances in molecular biology, precision medicine, artificial intelligence, imaging, and therapeutic innovation. ...

Future Directions in Genitourinary Oncology

Deadline 2027-03-07FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Genitourinary oncology is being reshaped by advances in molecular biology, precision medicine, artificial intelligence, imaging, and therapeutic innovation. ...

Mitochondrial Quality Control and Metabolic Reprogramming in Cancer: Implications for Tumor Progression, Immunity, and Therapy

Deadline 2027-03-08FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Mitochondria are increasingly recognized as central regulators of cancer cell fate, extending far beyond their classical role in bioenergetics. Alterations i...

Mitochondrial Quality Control and Metabolic Reprogramming in Cancer: Implications for Tumor Progression, Immunity, and Therapy

Deadline 2027-03-08FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Mitochondria are increasingly recognized as central regulators of cancer cell fate, extending far beyond their classical role in bioenergetics. Alterations i...

Precision Translational Research for HPV-Positive and HPV-Negative Tonsillar Squamous Cell Carcinoma: Molecular Mechanisms, MRD Monitoring, and Individualized Therapeutic Optimization

Deadline 2027-03-09FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Tonsillar squamous cell carcinoma represents the dominant and most clinically heterogeneous subsite of oropharyngeal squamous cell carcinoma (OPSCC), charact...

Precision Translational Research for HPV-Positive and HPV-Negative Tonsillar Squamous Cell Carcinoma: Molecular Mechanisms, MRD Monitoring, and Individualized Therapeutic Optimization

Deadline 2027-03-09FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Tonsillar squamous cell carcinoma represents the dominant and most clinically heterogeneous subsite of oropharyngeal squamous cell carcinoma (OPSCC), charact...

From 3D Virtual Planning to Precision Surgery: Advanced Visualization and Parenchymal-Sparing Strategies in Complex Oncologic Surgery

Deadline 2027-03-13FrontiersIndexed (Active)

Journal: Frontiers in Oncology

The increasing integration of advanced imaging, computational technologies and three-dimensional visualization is transforming the planning and the execution...

From 3D Virtual Planning to Precision Surgery: Advanced Visualization and Parenchymal-Sparing Strategies in Complex Oncologic Surgery

Deadline 2027-03-13FrontiersIndexed (Active)

Journal: Frontiers in Oncology

The increasing integration of advanced imaging, computational technologies and three-dimensional visualization is transforming the planning and the execution...

Imaging-Guided Re-irradiation and Adaptive Radiotherapy for Recurrent Glioblastoma

Deadline 2027-03-13FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Recurrent glioblastoma (rGBM) remains one of the hardest problems in neuro-oncology. At relapse, radiotherapy decisions are often limited by uncertain target...

Imaging-Guided Re-irradiation and Adaptive Radiotherapy for Recurrent Glioblastoma

Deadline 2027-03-13FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Recurrent glioblastoma (rGBM) remains one of the hardest problems in neuro-oncology. At relapse, radiotherapy decisions are often limited by uncertain target...

Exploring Oncolytic Virotherapy in Solid Tumor Treatment: Volume II

Deadline 2027-03-14FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Following the success of the first volume of the Research Topic "Exploring Oncolytic Virotherapy in Solid Tumor Treatment" (linked here), Volume II aims to c...

Exploring Oncolytic Virotherapy in Solid Tumor Treatment: Volume II

Deadline 2027-03-14FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Following the success of the first volume of the Research Topic "Exploring Oncolytic Virotherapy in Solid Tumor Treatment" (linked here), Volume II aims to c...

Advances in Supportive Care for Head and Neck Cancer: From Toxicity Prevention to Survivorship

Deadline 2027-03-16FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Head and neck oncology has advanced substantially through improved surgery, radiotherapy, systemic therapies, immunotherapy, and targeted treatments. Neverth...

Advances in Supportive Care for Head and Neck Cancer: From Toxicity Prevention to Survivorship

Deadline 2027-03-16FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Head and neck oncology has advanced substantially through improved surgery, radiotherapy, systemic therapies, immunotherapy, and targeted treatments. Neverth...

Advancing Therapy Planning and Treatment Response Assessment in Neuro-Oncology: From Morphological Imaging to Integrated Biomarkers

Deadline 2027-03-16FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Neuro-oncology faces persistent challenges in accurately defining tumor extent and assessing treatment response across primary and secondary brain tumors. In...

Advancing Therapy Planning and Treatment Response Assessment in Neuro-Oncology: From Morphological Imaging to Integrated Biomarkers

Deadline 2027-03-16FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Neuro-oncology faces persistent challenges in accurately defining tumor extent and assessing treatment response across primary and secondary brain tumors. In...

Next-Generation Paradigms in Head and Neck Oncology: From Precision Diagnostics and Targeted Platforms to Immunotherapy

Deadline 2027-03-16FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Immunotherapy has fundamentally rewritten the therapeutic paradigm for head and neck cancers, shifting the clinical standard of care from an exclusive relian...

Next-Generation Paradigms in Head and Neck Oncology: From Precision Diagnostics and Targeted Platforms to Immunotherapy

Deadline 2027-03-16FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Immunotherapy has fundamentally rewritten the therapeutic paradigm for head and neck cancers, shifting the clinical standard of care from an exclusive relian...

Perspectives in managing minimal residual disease and functional outcomes in head and neck pathology

Deadline 2027-03-16FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Minimal residual disease (MRD) detection has emerged as a transformative approach in head and neck oncology, offering unparalleled insights into tumor persis...

Perspectives in managing minimal residual disease and functional outcomes in head and neck pathology

Deadline 2027-03-16FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Minimal residual disease (MRD) detection has emerged as a transformative approach in head and neck oncology, offering unparalleled insights into tumor persis...

Advances in lung cancer metastasis: Mechanisms, biomarkers, and translational management

Deadline 2027-03-18FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Lung cancer remains the leading cause of cancer-related mortality worldwide, and metastatic disease accounts for the majority of this burden. Despite advance...

Advances in lung cancer metastasis: Mechanisms, biomarkers, and translational management

Deadline 2027-03-18FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Lung cancer remains the leading cause of cancer-related mortality worldwide, and metastatic disease accounts for the majority of this burden. Despite advance...

AI-Driven Liquid Biopsy Platforms for Early Detection and Longitudinal Monitoring of Solid Tumors

Deadline 2027-03-19FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Liquid biopsy has transformed oncology by enabling minimally invasive access to tumor derived material through circulating tumor DNA, cell free DNA, and rela...

AI-Driven Liquid Biopsy Platforms for Early Detection and Longitudinal Monitoring of Solid Tumors

Deadline 2027-03-19FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Liquid biopsy has transformed oncology by enabling minimally invasive access to tumor derived material through circulating tumor DNA, cell free DNA, and rela...

Advances in Medical and Surgical Treatment Strategies of Pancreatic Cancer

Deadline 2027-03-19FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Pancreatic cancer remains one of the most challenging malignancies in modern oncology, characterized by aggressive tumor biology, frequent presentation at an...

Advances in Medical and Surgical Treatment Strategies of Pancreatic Cancer

Deadline 2027-03-19FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Pancreatic cancer remains one of the most challenging malignancies in modern oncology, characterized by aggressive tumor biology, frequent presentation at an...

Advancing Multidisciplinary Approaches in Skull-Base Tumor Management: Volume II

Deadline 2027-03-19FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Following the success of the first volume of “Advancing Multidisciplinary Approaches in Skull-Base Tumor Management” here the Volume II edition will continue...

Advancing Multidisciplinary Approaches in Skull-Base Tumor Management: Volume II

Deadline 2027-03-19FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Following the success of the first volume of “Advancing Multidisciplinary Approaches in Skull-Base Tumor Management” here the Volume II edition will continue...

Diet, Nutritional Biomarkers and Functional Outcomes in the Management of Hematologic Malignancies

Deadline 2027-03-19FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Malnutrition, cachexia and sarcopenia are common in patients with hematologic malignancies and are strongly associated with poor tolerance of treatment, dela...

Diet, Nutritional Biomarkers and Functional Outcomes in the Management of Hematologic Malignancies

Deadline 2027-03-19FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Malnutrition, cachexia and sarcopenia are common in patients with hematologic malignancies and are strongly associated with poor tolerance of treatment, dela...

Grand Challenges in Bone and Soft Tissue Cancers

Deadline 2027-03-20FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Bone and soft tissue cancers encompass one of the most biologically heterogeneous groups of malignancies in oncology, spanning more than 100 histological sub...

Grand Challenges in Bone and Soft Tissue Cancers

Deadline 2027-03-20FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Bone and soft tissue cancers encompass one of the most biologically heterogeneous groups of malignancies in oncology, spanning more than 100 histological sub...

Predictive Models Revolutionizing Palliative Radiotherapy for Bone Metastases

Deadline 2027-03-20FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Palliative radiotherapy remains a cornerstone for the management of bone metastases, offering crucial relief from pain and preserving quality of life for pat...

Predictive Models Revolutionizing Palliative Radiotherapy for Bone Metastases

Deadline 2027-03-20FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Palliative radiotherapy remains a cornerstone for the management of bone metastases, offering crucial relief from pain and preserving quality of life for pat...

Radiation Oncology in Bone Cancers

Deadline 2027-03-20FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Bone cancers present unique clinical challenges for radiation oncologists, whether arising as primary malignancies or as metastatic disease from distant site...

Radiation Oncology in Bone Cancers

Deadline 2027-03-20FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Bone cancers present unique clinical challenges for radiation oncologists, whether arising as primary malignancies or as metastatic disease from distant site...

Innovative Delivery Strategies and Drug Repurposing to Overcome Treatment Resistance in Cancer

Deadline 2027-03-23FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Treatment resistance remains a central limitation in the pharmacological management of aggressive malignancies, including pancreatic cancer, glioblastoma, tr...

Innovative Delivery Strategies and Drug Repurposing to Overcome Treatment Resistance in Cancer

Deadline 2027-03-23FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Treatment resistance remains a central limitation in the pharmacological management of aggressive malignancies, including pancreatic cancer, glioblastoma, tr...

Biology-Driven Treatment Strategies in NSCLC: From Oncogene Addiction to Immunotherapy Integration

Deadline 2027-03-27FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Non-Small Cell Lung Cancer (NSCLC) has undergone a profound transformation over the past two decades, evolving from a histology-driven to a biology-driven di...

Biology-Driven Treatment Strategies in NSCLC: From Oncogene Addiction to Immunotherapy Integration

Deadline 2027-03-27FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Non-Small Cell Lung Cancer (NSCLC) has undergone a profound transformation over the past two decades, evolving from a histology-driven to a biology-driven di...

Chromothripsis and Copy Number Variation as Drivers of Precision Diagnostics in Lymphoma

Deadline 2027-03-27FrontiersIndexed (Active)

Journal: Frontiers in Oncology

The field of lymphoma genomics has witnessed groundbreaking advances in recent years, particularly in understanding the complex genetic events underlying dis...

Chromothripsis and Copy Number Variation as Drivers of Precision Diagnostics in Lymphoma

Deadline 2027-03-27FrontiersIndexed (Active)

Journal: Frontiers in Oncology

The field of lymphoma genomics has witnessed groundbreaking advances in recent years, particularly in understanding the complex genetic events underlying dis...

Refining Surgical Strategies in Metastatic Colorectal Cancer

Deadline 2027-03-27FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Colorectal cancer with metastatic disease remains a major surgical and oncologic challenge, despite advances in systemic therapy, cross-sectional imaging, in...

Refining Surgical Strategies in Metastatic Colorectal Cancer

Deadline 2027-03-27FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Colorectal cancer with metastatic disease remains a major surgical and oncologic challenge, despite advances in systemic therapy, cross-sectional imaging, in...

Tumor Organoids as Platforms for Precision Medicine: Current Status, Methodological Challenges, and Future Directions

Deadline 2027-03-27FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Patient-derived tumor organoids have emerged as a transformative preclinical model, bridging the gap between traditional two-dimensional cell cultures and th...

Tumor Organoids as Platforms for Precision Medicine: Current Status, Methodological Challenges, and Future Directions

Deadline 2027-03-27FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Patient-derived tumor organoids have emerged as a transformative preclinical model, bridging the gap between traditional two-dimensional cell cultures and th...

Management of Advanced Renal Cell Carcinoma

Deadline 2027-03-28FrontiersIndexed (Active)

Journal: Frontiers in Oncology

The treatment landscape for advanced renal cell carcinoma (RCC) has rapidly evolved with the emergence of immune checkpoint inhibitors, targeted therapies, a...

Management of Advanced Renal Cell Carcinoma

Deadline 2027-03-28FrontiersIndexed (Active)

Journal: Frontiers in Oncology

The treatment landscape for advanced renal cell carcinoma (RCC) has rapidly evolved with the emergence of immune checkpoint inhibitors, targeted therapies, a...

Thermal Reprogramming of the Tumor Immune Microenvironment: From Molecular Mechanisms to Clinical Translation

Deadline 2027-04-01FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Hyperthermia, defined as the controlled elevation of tissue temperature in the range of 39–45 °C, is increasingly recognized as a potent modulator of tumor b...

Thermal Reprogramming of the Tumor Immune Microenvironment: From Molecular Mechanisms to Clinical Translation

Deadline 2027-04-01FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Hyperthermia, defined as the controlled elevation of tissue temperature in the range of 39–45 °C, is increasingly recognized as a potent modulator of tumor b...

Bridging Preclinical Models and Clinical Translation in Combination Cancer Therapies

Deadline 2027-04-15FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Despite remarkable advances in cancer research, the translation of promising preclinical discoveries into clinically effective combination therapies remains ...

Bridging Preclinical Models and Clinical Translation in Combination Cancer Therapies

Deadline 2027-04-15FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Despite remarkable advances in cancer research, the translation of promising preclinical discoveries into clinically effective combination therapies remains ...

Cellular Heterogeneity and Intercellular Communication in the Tumor Microenvironment: Integrative Multi-Omics and Computational Approaches

Deadline 2027-04-30FrontiersIndexed (Active)

Journal: Frontiers in Oncology

The tumor microenvironment (TME) is a complex ecosystem in which malignant cells, immune populations, stromal components, and endothelial cells interact dyna...

Cellular Heterogeneity and Intercellular Communication in the Tumor Microenvironment: Integrative Multi-Omics and Computational Approaches

Deadline 2027-04-30FrontiersIndexed (Active)

Journal: Frontiers in Oncology

The tumor microenvironment (TME) is a complex ecosystem in which malignant cells, immune populations, stromal components, and endothelial cells interact dyna...

Small-Molecule Targeting of Oncogenic Signalling Pathways in Cancer

Deadline 2027-05-04FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Cancer progression is driven by dysregulated molecular signalling networks that control cell proliferation, survival, metabolism, and immune responses. Key p...

Small-Molecule Targeting of Oncogenic Signalling Pathways in Cancer

Deadline 2027-05-04FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Cancer progression is driven by dysregulated molecular signalling networks that control cell proliferation, survival, metabolism, and immune responses. Key p...

Oncogenic Dependencies and Therapeutic Vulnerabilities in Solid Tumours: From Functional Genomics to Translational Biomarkers

Deadline 2027-05-18FrontiersIndexed (Active)

Journal: Frontiers in Oncology

The field of cancer biology has been revolutionized by advances in genomics and targeted therapies, yet major challenges persist in the management of solid t...

Oncogenic Dependencies and Therapeutic Vulnerabilities in Solid Tumours: From Functional Genomics to Translational Biomarkers

Deadline 2027-05-18FrontiersIndexed (Active)

Journal: Frontiers in Oncology

The field of cancer biology has been revolutionized by advances in genomics and targeted therapies, yet major challenges persist in the management of solid t...

AI-Enabled Digital Pathology and Molecular Biomarker Assessment for Clinical Decision Support in Breast Cancer

Deadline 2027-06-30FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Breast cancer diagnosis and management increasingly depend on the accurate assessment of tissue-based and molecular biomarkers that guide prognosis, therapeu...

AI-Enabled Digital Pathology and Molecular Biomarker Assessment for Clinical Decision Support in Breast Cancer

Deadline 2027-06-30FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Breast cancer diagnosis and management increasingly depend on the accurate assessment of tissue-based and molecular biomarkers that guide prognosis, therapeu...

Cancer Vaccine Immunotherapy for Solid and Hematologic Malignancies

Deadline 2027-06-30FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Cancer vaccines are re-emerging as a credible immunotherapy class, propelled by advances in antigen discovery, vaccine engineering, and combination strategie...

Cancer Vaccine Immunotherapy for Solid and Hematologic Malignancies

Deadline 2027-06-30FrontiersIndexed (Active)

Journal: Frontiers in Oncology

Cancer vaccines are re-emerging as a credible immunotherapy class, propelled by advances in antigen discovery, vaccine engineering, and combination strategie...

The Evolving Role of Neoadjuvant Immunotherapy and the Biomarkers Available in Decision-Making

Deadline 2027-06-30FrontiersIndexed (Active)

Journal: Frontiers in Oncology

The application of immunotherapy has profoundly changed the field of oncology, with immune checkpoint inhibitors and related agents now recognized as a mains...

The Evolving Role of Neoadjuvant Immunotherapy and the Biomarkers Available in Decision-Making

Deadline 2027-06-30FrontiersIndexed (Active)

Journal: Frontiers in Oncology

The application of immunotherapy has profoundly changed the field of oncology, with immune checkpoint inhibitors and related agents now recognized as a mains...

Reference integrity note: verify every citation against the original source before submission, including publication year, journal title, volume/issue, page range, DOI, and the target journal style.